Showing results (41-50 of 51) with videos related to
Sort By:
Pageof 6
Bioorganic & Medicinal Chemistry Letters|May 18, 1999
Thiazolo[4,5-d]pyrimidine thiones and -ones as corticotropin-releasing hormone (CRH-R1) receptor antagonistsJ P Beck, M A Curry, R J Chorvat, et al.Endocrinology|June 1, 1991
Role for brain corticotropin-releasing factor in the weight-reducing effects of chronic fenfluramine treatment in ratsN M Appel, M J Owens, S Culp, et al.Archives of Neurology|August 1, 1988
Cerebrospinal fluid correlates of depression in Huntington's diseaseR Kurlan, E Caine, A Rubin, et al.Bioorganic & Medicinal Chemistry Letters|May 7, 1999
Purin-8-ones as corticotropin-releasing hormone (CRH-R1) receptor antagonistsJ P Beck, A G Arvanitis, M A Curry, et al.Molecular Psychiatry|January 7, 2015
Distinctive transcriptome alterations of prefrontal pyramidal neurons in schizophrenia and schizoaffective disorderD Arion, J P Corradi, S Tang, et al.The Journal of Pharmacology and Experimental Therapeutics|May 15, 1998
Two new potent neurotransmitter release enhancers, 10,10-bis(4-pyridinylmethyl)-9(10H)-anthracenone and 10,10-bis(2-fluoro-4-pyridinylmethyl)-9(10H)-anthracenone: comparison to linopirdineR Zaczek, R J Chorvat, J A Saye, et al.Journal of Medicinal Chemistry|February 12, 2000
4-(1,3-Dimethoxyprop-2-ylamino)-2,7-dimethyl-8-(2, 4-dichlorophenyl)pyrazolo[1,5-a]-1,3,5-triazine: a potent, orally bioavailable CRF(1) receptor antagonistL He, P J Gilligan, R Zaczek, et al.Journal of Medicinal Chemistry|November 7, 1998
2-Fluoro-4-pyridinylmethyl analogues of linopirdine as orally active acetylcholine release-enhancing agents with good efficacy and duration of actionR A Earl, R Zaczek, C A Teleha, et al.Bioorganic & Medicinal Chemistry|September 1, 2000
The discovery of 4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1 ,5-a]-pyrimidine: a corticotropin-releasing factor (hCRF1) antagonistP J Gilligan, C Baldauf, A Cocuzza, et al.The Journal of Biological Chemistry|August 1, 2000
Presenilin-1 and -2 are molecular targets for gamma-secretase inhibitorsD Seiffert, J D Bradley, C M Rominger, et al.Pageof 6